|
Volumn 28, Issue 4, 2001, Pages 418-425
|
Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine
|
Author keywords
Gemcitabine; Glucose metabolism; Hepatoma; Programmed cell death
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
GALLIUM 68;
GEMCITABINE;
GERMANIUM;
ANIMAL CELL;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CANCER CHEMOTHERAPY;
CELL DEATH;
CONTROLLED STUDY;
HEPATOMA CELL;
LIVER CELL CARCINOMA;
NONHUMAN;
POSITRON EMISSION TOMOGRAPHY;
RAT;
TREATMENT OUTCOME;
WHOLE BODY SCANNER;
3-O-METHYLGLUCOSE;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
APOPTOSIS;
DEOXYCYTIDINE;
DNA, NEOPLASM;
FLUORODEOXYGLUCOSE F18;
GLUCOSE;
IMMUNOHISTOCHEMISTRY;
LIVER NEOPLASMS, EXPERIMENTAL;
NEOPLASM TRANSPLANTATION;
PHOSPHORYLATION;
RADIOPHARMACEUTICALS;
RATS;
RATS, INBRED STRAINS;
THYMIDINE;
TOMOGRAPHY, EMISSION-COMPUTED;
TUMOR CELLS, CULTURED;
|
EID: 0035096660
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/s002590100489 Document Type: Article |
Times cited : (44)
|
References (31)
|